Culled from a list of 200 nominations from around the world, the BIS Research and Insight Monk initiative showcases and celebrates the diversity and talent among the interdisciplinary leaders of the healthcare industry and highlights their influence on the industry.
“We went through a rigorous process of analysing the initial pool of nominations and shortlisting the Top 25 Voices through an iterative process based on eight core parameters including product developments, publications, entrepreneurial achievements, and years of experience, among others,” said Wahid Khan, principal analyst at BIS Research.
As the Chief Technical Officer of DNAnexus, George has played a critical role in building the company’s scientific and engineering foundation and exploring ways in which our technology can be used to craft novel experiences that transcend traditional genomics boundaries.
In the Insight Monk report, he spoke about genetic testing.
“Clinical sequencing is increasingly applied in oncology to advance personalized treatment of cancer, identification and treatment of Mendelian diseases, and in prenatal genetic testing,” he said.
Congratulations to George and his fellow awardees, which also includes George D. Yancopoulos, President and Chief Scientific Officer of Regeneron Pharmaceuticals, Inc., one of our collaborators for the UK Biobank project.
